论文部分内容阅读
Goals: To assess the incidence of oral complementary and alternative medicine (CAM) usage by gastroenterology patients at a single university center and comp are against controls. Background: The public awareness and usage of CAM have inc reased. The use of CAM has been described in patients with functional bowel diso rders; however, their role in patients with gastrointestinal disease is less cle ar. Study: Patients attending luminal gastroenterology clinics and customers at local supermarkets completed a 30- point, structured questionnaire assessing th eir use of CAM. Results: A total of 1,409 subjects were recruited. The incidence of CAM use was 49.5% for inflammatory bowel disease, 50.9% for irritable bo wel syndrome, 20% for general gastrointestinal diseases, and 27% for control s. Pearson’ s χ 2 tests showed that patients with inflammatory bowel disease ( IBD) or irritable bowel syndrome were more likely to use CAM than controls (P < 0.001). Binary logistic regression analysis showed that females were more likely to take CAM than men (P < 0.05). Conclusions: The percentage of CAM users among patients with IBD is similar to those with a functional diagnosis. Increasing n umbers of IBD patients are using CAM in addition to conventional therapy. Awaren ess of this may prevent adverse CAM and conventional drug interactions.
Goals: To assess the incidence of oral complementary and alternative medicine (CAM) usage by gastroenterology patients at a single university center and comp are against controls. Background: The public awareness and usage of CAM have incased. The use of CAM has been described in patients with functional bowel diso rders; however, their role in patients with gastrointestinal disease is less cle ar. Study: Patients attended luminal gastroenterology clinics and customers at local supermarkets completed a 30- point, structured questionnaire assessing th eir use of CAM. : A total of 1,409 subjects were recruited. The incidence of CAM use was 49.5% for inflammatory bowel disease, 50.9% for irritable bo wel syndrome, 20% for general gastrointestinal diseases, and 27% for control s. Pearson ’s 2 tests showed that patients with inflammatory bowel disease (IBD) or irritable bowel syndrome were more likely to use CAM than controls (P <0.001). Binary logistic regression analysis s How to that females were more likely to take CAM than men (P <0.05). Conclusions: The percentage of CAM users among patients with IBD is similar to those with a functional diagnosis. Increasing nmbers of IBD patients are using CAM in addition to conventional therapy. Awaren ess of this may prevent adverse effects in CAM and conventional drug interactions.